James M. Thorburn
Net Worth
Last updated:
What is James M. Thorburn net worth?
The estimated net worth of Mr. James M. Thorburn is at least $13,438,393 as of 23 May 2023. He owns shares worth $1,104,043 as insider, has earned $7,704,090 from insider trading and has received compensation worth at least $4,630,260 in Twist Bioscience Corporation.
What is the salary of James M. Thorburn?
Mr. James M. Thorburn salary is $771,710 per year as Chief Financial Officer in Twist Bioscience Corporation.
How old is James M. Thorburn?
Mr. James M. Thorburn is 69 years old, born in 1956.
What stocks does James M. Thorburn currently own?
As insider, Mr. James M. Thorburn owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Twist Bioscience Corporation (TWST) | Chief Financial Officer | 38,831 | $28.43 | $1,104,043 |
What does Twist Bioscience Corporation do?
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.
James M. Thorburn insider trading
Twist Bioscience Corporation
Mr. James M. Thorburn has made 34 insider trades between 2019-2023, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 70,000 units of TWST stock on 8 Sep 2020. As of 23 May 2023 he still owns at least 38,831 units of TWST stock.
Twist Bioscience key executives
Twist Bioscience Corporation executives and other stock owners filed with the SEC:
- Dr. Emily Marine Leproust Ph.D. (52) Co-Founder, Chairman, Pres & Chief Executive Officer
- Dr. Patrick John Finn Ph.D. (53) Chief Commercial Officer
- Dr. William Charles Banyai Ph.D. (70) Senior Vice President of Advanced Devel., GM of Data Storage & Director
- Mr. James M. Thorburn (69) Chief Financial Officer
- Mr. Patrick Weiss (54) Chief Operating Officer